A possible genetic defect in 25-hydroxylation as a cause of rickets

J Pediatr. 1994 Jun;124(6):929-32. doi: 10.1016/s0022-3476(05)83184-1.

Abstract

We examined two siblings who had severe rickets at ages 2 and 7 years, respectively, despite a history of adequate vitamin D intake. The patients' sera had calcium concentrations at the lower limits of normal, low phosphate concentrations, elevated alkaline phosphatase activity, and low levels of 25-hydroxyvitamin D. Treatment with high doses of vitamin D2 resulted in resolution of the biochemical abnormalities and radiographic deformities; pharmacologic doses of vitamin D2 were required to maintain normal concentrations of 25-hydroxyvitamin D in the serum even though vitamin D absorption was normal. These children may have a genetic defect of the 25-hydroxylation step in vitamin D activation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 25-Hydroxyvitamin D 2 / metabolism
  • Child
  • Child, Preschool
  • Humans
  • Hydroxylation
  • Rickets / genetics*
  • Rickets / metabolism*
  • Vitamin D / metabolism*

Substances

  • Vitamin D
  • 25-Hydroxyvitamin D 2